DOI QR코드

DOI QR Code

Epac2a-knockout mice are resistant to dexamethasone-induced skeletal muscle atrophy and short-term cold stress

  • Song, Seung-Eun (Department of Physiology & Obesity-mediated Disease Research Center, Keimyung University School of Medicine) ;
  • Shin, Su-Kyung (Department of Physiology & Obesity-mediated Disease Research Center, Keimyung University School of Medicine) ;
  • Park, So-Young (Department of Physiology, Yeungnam University School of Medicine) ;
  • Hwang, Il-Seon (Department of Physiology & Obesity-mediated Disease Research Center, Keimyung University School of Medicine) ;
  • Im, Seung-Soon (Department of Physiology & Obesity-mediated Disease Research Center, Keimyung University School of Medicine) ;
  • Bae, Jae-Hoon (Department of Physiology & Obesity-mediated Disease Research Center, Keimyung University School of Medicine) ;
  • Choi, Myung-Sook (Department of Food Science and Nutrition, Kyungpook National University) ;
  • Song, Dae-Kyu (Department of Physiology & Obesity-mediated Disease Research Center, Keimyung University School of Medicine)
  • 투고 : 2017.07.14
  • 심사 : 2017.11.23
  • 발행 : 2018.01.31

초록

Exchange protein directly activated by cAMP (Epac) 2a-knockout (KO) mice exhibit accelerated diet-induced obesity and are resistant to leptin-mediated adipostatic signaling from the hypothalamus to adipose tissue, with sustained food intake. However, the impact of Epac2a deficiency on hypothalamic regulation of sympathetic nervous activity (SNA) has not been elucidated. This study was performed to elucidate the response of Epac2a-KO mice to dexamethasone-induced muscle atrophy and acute cold stress. Compared to age-matched wild-type mice, Epac2a-KO mice showed higher energy expenditures and expression of myogenin and uncoupling protein-1 in skeletal muscle (SM) and brown adipose tissue (BAT), respectively. Epac2a-KO mice exhibited greater endurance to dexamethasone and cold stress. In wild-type mice, exogenous leptin mimicked the responses observed in Epac2a-KO mice. This suggests that leptin-mediated hypothalamic signaling toward SNA appears to be intact in these mice. Hence, the potentiated responses of SM and BAT may be due to their high plasma leptin levels.

키워드

참고문헌

  1. Seino S and Shibasaki T (2005) PKA-dependent and pka-independent pathways for cAMP-regulated exocytosis. Physiol Rev 85, 1303-1342 https://doi.org/10.1152/physrev.00001.2005
  2. Takahashi H, Shibasaki T, Park JH et al (2015) Role of Epac2A/Rap1 signaling in interplay between incretin and sulfonylurea in insulin secretion. Diabetes 64, 1262-1272 https://doi.org/10.2337/db14-0576
  3. Schmidt M, Dekker FJ and Maarsingh H (2013) Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions. Pharmacol Rev 65, 670-709 https://doi.org/10.1124/pr.110.003707
  4. Hwang M, Go Y, Park JH et al (2017) Epac2a-null mice exhibit obesity-prone nature more susceptible to leptin resistance. Int J Obes 41, 279-288 https://doi.org/10.1038/ijo.2016.208
  5. Huxing C, Miguel L and Kamal R (2017) The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol 13, 338-351 https://doi.org/10.1038/nrendo.2016.222
  6. Morgan DA, Thedens DR, Weiss R and Rahmouni K (2008) Mechanisms mediating renal sympathetic activation to leptin in obesity. Am J Physiol Regul Integr Comp Physiol 295, R1730-R1736 https://doi.org/10.1152/ajpregu.90324.2008
  7. Caro JF, Kolaczynski JW, Nyce MR et al (1996) Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348, 159-161 https://doi.org/10.1016/S0140-6736(96)03173-X
  8. Banks WA (2001) Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. Curr Pharm Des 7, 125-133 https://doi.org/10.2174/1381612013398310
  9. Magni P, Liuzzi A, Ruscica M et al (2005) Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin sensitivity, lipid profile and macronutrient preference. Clin Endocrinol 62, 189-196 https://doi.org/10.1111/j.1365-2265.2005.02195.x
  10. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS and Kahn BB (1996) Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 45, 1638-1643 https://doi.org/10.2337/diab.45.11.1638
  11. Schwartz MW, Peskind E, Raskind M, Boyko EJ and Porte D Jr (1996) Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2, 589-593 https://doi.org/10.1038/nm0596-589
  12. Nickki O, Parinaz M, Belen R et al (2015) Diet-induced obese mice retain endogenous leptin action. Cell Metab 6, 877-882
  13. Haynes WG, Morgann DA, Djalali A et al (1999) Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33, 542-547 https://doi.org/10.1161/01.HYP.33.1.542
  14. Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8, 571-578 https://doi.org/10.1038/nn1455
  15. Cowley MA, Smart JL, Rubinstein M et al (2001) Leptin activates anorexingenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484 https://doi.org/10.1038/35078085
  16. Simonds SE, Pryor JT, Ravussin E et al (2014) Leptin mediates the increase in blood pressure associated with obesity. Cell 159, 1404-1416 https://doi.org/10.1016/j.cell.2014.10.058
  17. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE et al (1997) Direct effects of leptin on brown and white adipose tissue. J Clin Invest 100, 2858-2864 https://doi.org/10.1172/JCI119834
  18. Maroni P, Bendinelli R, Piccoletti R (2003) Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol Cell Endocrinol 201, 109-121 https://doi.org/10.1016/S0303-7207(02)00427-6
  19. Gema F (2006) Intracellular signalling pathways activated by leptin. Biochem J 393, 7-20 https://doi.org/10.1042/BJ20051578
  20. Bai Y, Zhang SY, Kim KS, Lee JK and Kim KH (1996) Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 271, 13939-13942 https://doi.org/10.1074/jbc.271.24.13939
  21. Bartness TJ, Vaughan CH and CK Song (2010) Sympathetic and sensory innervation of brown adipose tissue. Int J Obes (Lond) 34, S36-S42 https://doi.org/10.1038/ijo.2010.182
  22. Enriori PJ, Sinnayah P, Simonds SE, Rudaz CG and Cowley MA (2011) Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J Neurosci 31, 12189-12197 https://doi.org/10.1523/JNEUROSCI.2336-11.2011
  23. Hwa JJ, Fawzi AB, Graziano MP et al (1997) Leptin increase energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol 272, R1204-1209
  24. Scott MM, Lachey JL, Sternson SM et al (2009) Leptin targets in the mouse brain. J Comp Neurol 514, 518-532 https://doi.org/10.1002/cne.22025
  25. Margetic S, Gazzola C, Pegg GG and Hill RA (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes Rel Metab Disord 26, 1407-1433 https://doi.org/10.1038/sj.ijo.0802142
  26. Sainz N, Rodriguez A, Catalan V, Becerril S and Ramirez B (2009) Leptin administration favors muscle mass accretion by decreasing fox03a and Increasing PGC-1a in ob/ob mice. PLoS One 4, e6808 https://doi.org/10.1371/journal.pone.0006808
  27. Hamrick MW, Pennington C, Newton D, Xie D and Isales CM (2004) Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34, 376-383 https://doi.org/10.1016/j.bone.2003.11.020
  28. Pansters NA, Langen RC, Wouters E and Schols AM (2012) Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling. J Appl Phys 114, 1329-1339
  29. Allen D, Clearly A, Speaker K et al (2008) Myostatin, activin receptor IIB, and follistatin-like-3 gene are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 294, E918-E927 https://doi.org/10.1152/ajpendo.00798.2007
  30. Hamrick MW, Herberg S, Arounleut P et al (2010) The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun 400, 379-383 https://doi.org/10.1016/j.bbrc.2010.08.079
  31. Lynch GS and Ryall JG (2008) Role of $\beta$-adrenoceptor signaling in skeletal muscle: implication for muscle wasting and disease. Physiol Rev 88, 729-767 https://doi.org/10.1152/physrev.00028.2007
  32. Maroni P, Bendinelli P and Piccoletti R (2003) Early Intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol Cell Endocrinol 201, 109-121 https://doi.org/10.1016/S0303-7207(02)00427-6
  33. Hasselgren PO, Wray C and Mammen J (2002) Molecular regulation of muscle cachexia: it may be more than the proteasome. Biochem Biophys Res Commun 290, 1-10 https://doi.org/10.1006/bbrc.2001.5849
  34. Romanick M, Thompson LV and Brown-Borg HM (2013) Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle. Biochim Biophys Acta 1832, 1410-1420 https://doi.org/10.1016/j.bbadis.2013.03.011